Stock analysts at Credit Suisse Group AG started coverage on shares of Humana Inc. (NYSE:HUM) in a note issued to investors on Thursday. The brokerage set a “neutral” rating and a $256.00 price target on the insurance provider’s stock. Credit Suisse Group AG’s price target would indicate a potential upside of 0.25% from the company’s previous close.

HUM has been the topic of a number of other research reports. Deutsche Bank AG lifted their price target on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Oppenheimer Holdings, Inc. lifted their price target on shares of Humana from $236.00 to $255.00 and gave the stock an “outperform” rating in a report on Thursday, August 3rd. BidaskClub lowered shares of Humana from a “hold” rating to a “sell” rating in a report on Thursday, August 17th. ValuEngine lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $257.00 price target on shares of Humana in a report on Friday, October 13th. Thirteen analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $253.71.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. The company had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same quarter in the previous year, the business earned $2.30 earnings per share.

TRADEMARK VIOLATION NOTICE: “Humana Inc. (HUM) Receives New Coverage from Analysts at Credit Suisse Group AG” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/11/02/humana-inc-hum-receives-new-coverage-from-analysts-at-credit-suisse-group-ag.html.

In other news, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the completion of the sale, the chief executive officer now directly owns 80,086 shares of the company’s stock, valued at $20,172,061.68. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider William Kevin Fleming sold 3,071 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total transaction of $770,759.58. Following the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 55,595 shares of company stock valued at $14,133,706. Insiders own 0.80% of the company’s stock.

Several large investors have recently bought and sold shares of HUM. Bank of Nova Scotia increased its position in shares of Humana by 4.6% during the first quarter. Bank of Nova Scotia now owns 3,478 shares of the insurance provider’s stock worth $717,000 after acquiring an additional 152 shares in the last quarter. Columbia Partners L L C Investment Management increased its position in shares of Humana by 14.4% during the first quarter. Columbia Partners L L C Investment Management now owns 9,200 shares of the insurance provider’s stock worth $1,896,000 after acquiring an additional 1,158 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of Humana by 3.0% during the first quarter. Nomura Asset Management Co. Ltd. now owns 29,173 shares of the insurance provider’s stock worth $6,013,000 after acquiring an additional 858 shares in the last quarter. Independent Portfolio Consultants Inc. increased its position in shares of Humana by 22.1% during the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after acquiring an additional 94 shares in the last quarter. Finally, Xact Kapitalforvaltning AB increased its position in shares of Humana by 2.0% during the second quarter. Xact Kapitalforvaltning AB now owns 23,365 shares of the insurance provider’s stock worth $5,622,000 after acquiring an additional 455 shares in the last quarter. 95.79% of the stock is owned by institutional investors.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.